Business Wire

New Members Have Joined HD-PLC Alliance to Accelerate the HD-PLC Advancement Towards a Global Power Line Communication Standard

3.8.2021 16:00:00 EEST | Business Wire | Press release

Share

HD-PLC Alliance (*1), Fukuoka, Japan (Alliance) announced that 4 newcomers has joined the alliance this year. The member list on Alliance website was updated as follows;

MicroChip Technology as Supporter since July, is a leading provider of smart, connected and secure embedded control solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs which reduce risk while lowering total system cost and time to market. The company’s solutions serve more than 120,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Microchip is headquartered in Chandler, Arizona.

LVX Global, as Supporter since May, is an international technology solutions business that identifies, designs, delivers and manages high value, scalable, replicable social outcomes at the intersection of technology, engineering, and human behavioural science.

Helvetia, as Standard since May, is a Japanese company. Based on long-time accumulated, experienced knowledge of the industrial field that requires reliability, Helvetia supports enthusiastically to solve customers’ problems of hardware and software design.

And Shanghai Clouder Semiconductor, as Supporter since April, founded in July 2012, is a fabless design house. The company’s main product CR600 uses HD-PLC Inside Plus technology. CR600 application field is mainly two-wire door-phone System.

Since its establishment in 2007, the Alliance has carried out global activities in Europe, U.S.A, Asia to expand and disseminate HD-PLC (*2) and to ensure interoperability. As a result, the global IEEE Standard 1901 (*3) was approved in 2010, adopting HD-PLC as a core technology. "The IEEE 1901 standard is the FIRST standard that converted scattered initiatives into a profitable industry offering assurance of interoperability to users” said Jean-Philippe Faure, IEEE 1901 Working Group Chair. IEEE 1901 has updated as “IEEE 1901 std-2020” early this year to move forward to the 2nd decade.

Comments from these members;
“Microchip is delighted to join the HD-PLC Alliance and extend our product offering with innovative, open-standard and scalable technology solutions. As a leading supplier of total system solutions for smart, connected and secure technology, we look forward to the HD-PLC as a terrific addition to our offering of wired solutions, particularly in the areas of Internet of Things (IoT) and smart energy applications," said Andres Munoz, Marketing Manager, Smart Energy Communications at MicroChip.

“LVX Global is excited to join the HD-PLC Alliance, our participation is part of our belief in building an international global power line communication standard, and is core to having open and reliable communications as well as sustainable systems for the management of smart cities“ said Matthias Lürkens, GM Connectivity & Standardization for LVX Global.

“Helvetia is excited to join the HD-PLC Alliance. Our participation aims to make smart city management a sustainable system using HD-PLC.” said Katsushi Mori, CEO of Helvetia.

“Panasonic's HD-PLC technology provides a cost-effective, safe and reliable simple way for the two-wire door-phone system. We are very happy to be able to introduce HD-PLC Inside Plus technology into the Clouder’s CR600 chip to help customers achieve better efficiency and stability in use. It is a great honor to join the HD-PLC alliance, wish the alliance better and better.” said Lee Jichuan, CEO of Shanghai Clouder Semiconductor.

The Alliance held HD-PLC global web seminars or “Webinars” jointly with IEEE SA in March and June, and explores to organize next Webinar this fall.

The Alliance welcomes other new member to together expand the use of HD-PLC across various use cases in countries around the world.

Note:

*1: The unincorporated association founded by Panasonic Corporation in 2017, which aims to expand and increase the use of HD-PLC and ensure interoperability between equipment with built-in HD-PLC.
*2: HD-PLC™ or HD-PLC™ mark is a registered trademark or trademark of Panasonic Corporation in Japan and in other countries.
*3: IEEE: Institute of Electrical and Electronics Engineers, U.S.A. The global standard on high-speed Power Line Communication that adopted HD-PLC as core technology in 2010. The latest revision, IEEE 1901 std-2020, has been published in January 2021.
https://standards.ieee.org/standard/1901-2020.html

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

HD-PLC Alliance
Ryoji Kido,
E-mail: info@hd-plc.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye